Lemon Healthcare is on the verge of listing on the KOSDAQ. Market attention is focusing on the company's growth potential as a specialized medical data platform company.

■ Real-time Collection and Standardization of Medical Data as Core Competitiveness

Lemon Healthcare is a software development and supply company whose core competitiveness lies in its platform technology that collects medical data generated at hospitals in real time, standardizes it, and then converts and links it for various utilization purposes.

Key products include the smart hospital relay platform 'LDB-H,' the medical data ecosystem linkage platform 'LDB-D,' and the customized health data relay platform 'LDB-E.' These platforms serve as foundational technologies supporting data utilization among medical institutions, patients, and enterprises.

■ IPO Price Set at 10,000 Won, Demand Forecast Records 1,238 to 1

A total of 2 million shares are being offered through this initial public offering (IPO). The final offer price was set at 10,000 won, the upper end of the desired price band, with the total offering amounting to 20 billion won. The institutional investor demand forecast recorded a competition rate of 1,238 to 1, demonstrating high interest. The shares allocated to general investors amount to 500,000 to 600,000 shares, with KB Securities serving as the lead underwriter.

■ Differentiation from B2C-Centric Companies… 'Focusing on Medical Data Distribution Platform'

Unlike existing digital healthcare companies that pursue reservation services or commerce-centric B2C business models, Lemon Healthcare differentiates itself by focusing on a platform business for the distribution and utilization of medical data.

The company aims to establish a service that comprehensively manages an individual's medical MyData from birth through old age. It aspires to create a digital healthcare ecosystem where various participants, including hospitals, patients, and enterprises, can safely utilize medical information.

The industry projects that as the utilization of medical data and the digital healthcare market continue to expand, the importance of data linkage services based on platform technology will grow further. Following the listing, investor attention is expected to remain on how much Lemon Healthcare will expand its medical information platform business.

[This article was written with the assistance of AI. This article is for reference purposes only for investment decisions and does not recommend buying or selling any specific stock. The ultimate responsibility for investment decisions lies with the investor.]